David Cook has more than 20 years of experience in organizational management and operations in the biotechnology industry. In his role at IAVI, Cook oversees IAVI’s senior management team and works closely with IAVI’s CEO to put the organization’s long-term strategy for AIDS vaccine development into effect. Over the course of his career, Cook has held senior positions in such areas as R&D, program management, business development, manufacturing, and clinical and regulatory affairs.

Before joining IAVI, Cook was a consultant for BIO Ventures for Global Health, a nonprofit based in Washington D.C., that seeks to apply the resources and capabilities of the biotechnology industry to develop vaccines, drugs and diagnostics for neglected diseases. In this capacity, he helped BVGH with its business development activities, contributed to the establishment of viable partnerships between companies, NGOs and academic institutions and devised incentives to make participation in global health ventures feasible for commercial enterprises. Immediately before BVGH, Cook was the CEO and co-founder of Anza Therapeutics, a biotechnology start-up company developing a novel vaccine platform to induce cellular immune responses to fight or prevent diseases such as cancer, hepatitis C, malaria and tuberculosis.